{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T16:29:36Z","timestamp":1769185776213,"version":"3.49.0"},"reference-count":50,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.3892\/ijmm.2014.1662","type":"journal-article","created":{"date-parts":[[2014,2,19]],"date-time":"2014-02-19T08:54:36Z","timestamp":1392800076000},"page":"1131-1139","source":"Crossref","is-referenced-by-count":6,"title":["Effects of phased joint intervention on IL-35 and IL-17 expression levels in patients with portal hypertension"],"prefix":"10.3892","volume":"33","author":[{"given":"YUGANG","family":"WANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JINBIN","family":"DONG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WENYING","family":"MENG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIALI","family":"MA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NA","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUE","family":"WEI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MIN","family":"SHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,2,19]]},"reference":[{"key":"key20180107231613_b1-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0889-8553(03)00099-2","article-title":"Portal hypertensive bleeding","volume":"32","author":"Comar","year":"2003","journal-title":"Gastroenterol Clin North Am"},{"key":"key20180107231613_b2-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4254\/wjh.v2.i7.261","article-title":"Acute esophageal variceal bleeding: Current strategies and new perspectives","volume":"2","author":"Augustin","year":"2010","journal-title":"World J Hepatol"},{"key":"key20180107231613_b3-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.gie.2006.08.023","article-title":"Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database","volume":"65","author":"Kovalak","year":"2007","journal-title":"Gastrointest Endosc"},{"key":"key20180107231613_b4-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","article-title":"Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis","volume":"353","author":"Groszmann","year":"2005","journal-title":"The N Engl J Med"},{"key":"key20180107231613_b5-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0168-8278(02)00420-8","article-title":"Incidence and natural history of small esophageal varices in cirrhotic patients","volume":"38","author":"Merli","year":"2003","journal-title":"J Hepatol"},{"key":"key20180107231613_b6-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-2007-1007133","article-title":"Pharmacological treatment of portal hypertension: an evidence-based approach","volume":"19","author":"D\u2019Amico","year":"1999","journal-title":"Semin Liver Dis"},{"key":"key20180107231613_b7-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0140-6736(03)12778-X","article-title":"Prevention of variceal rebleeding","volume":"361","author":"Bosch","year":"2003","journal-title":"Lancet"},{"key":"key20180107231613_b8-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2005.05.009","article-title":"Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension","volume":"43","author":"de Franchis","year":"2005","journal-title":"J Hepatol"},{"key":"key20180107231613_b9-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/028418517401500509","article-title":"Sclerosing injection of esophageal varices through transhepatic selective catheterization of the gastric coronary vein. A preliminary report","volume":"15","author":"Lunderquist","year":"1974","journal-title":"Acta Radiol Diagn (Stockh)"},{"key":"key20180107231613_b10-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0016-5085(83)80241-8","article-title":"Clinical outcome after percutaneous transhepatic obliteration of esophageal varices","volume":"85","author":"Benner","year":"1983","journal-title":"Gastroenterology"},{"key":"key20180107231613_b11-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000050126","article-title":"Correlation between endoscopic and angiographic findings in patients with esophageal and isolated gastric varices","volume":"18","author":"Chikamori","year":"2001","journal-title":"Dig Surg"},{"key":"key20180107231613_b12-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2214\/ajr.152.4.755","article-title":"Percutaneous transhepatic embolization of gastroesophageal varices: results in 400 patients","volume":"152","author":"L\u2019Hermine","year":"1989","journal-title":"AJR Am J Roentgenol"},{"key":"key20180107231613_b13-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jvir.2006.12.734","article-title":"Partial splenic embolization in the treatment of patients with portal hypertension: a review of the english language literature","volume":"18","author":"Koconis","year":"2007","journal-title":"J Vasc Interv Radiol"},{"key":"key20180107231613_b14-ijmm-33-05-1131","first-page":"63","article-title":"Clinical study of combined interventional treatment of portal hypertension","volume":"11","author":"Shi","year":"2010","journal-title":"Chin J Ethnomed Ethnopharm"},{"key":"key20180107231613_b15-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1042\/CS20060242","article-title":"Liver fibrosis: cellular mechanisms of progression and resolution","volume":"112","author":"Henderson","year":"2007","journal-title":"Clin Sci (Lond)"},{"key":"key20180107231613_b16-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.gastro.2009.04.011","article-title":"Kupffer cells mediate leptin-induced liver fibrosis","volume":"137","author":"Wang","year":"2009","journal-title":"Gastroenterology"},{"key":"key20180107231613_b17-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"e1000371","DOI":"10.1371\/journal.ppat.1000371","article-title":"Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis","volume":"5","author":"Pesce","year":"2009","journal-title":"PLoS Pathog"},{"key":"key20180107231613_b18-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1189\/JLB.0309135","article-title":"Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases","volume":"86","author":"Gao","year":"2009","journal-title":"J Leukoc Biol"},{"key":"key20180107231613_b19-ijmm-33-05-1131","first-page":"1219","article-title":"Regulatory T-cells and hepatocellular carcinoma: implication of the regulatory T lymphocytes in the control of the immune response","volume":"95","author":"Delhem","year":"2008","journal-title":"Bull Cancer"},{"key":"key20180107231613_b20-ijmm-33-05-1131","first-page":"1029","article-title":"Role of the regulatory T lymphocytes in hepatitis C fibrosis progression","volume":"95","author":"Delhem","year":"2008","journal-title":"Bull Cancer"},{"key":"key20180107231613_b21-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/0016-5085(86)91127-3","article-title":"Measurement of portal vascular resistance in patients with portal hypertension","volume":"90","author":"Moriyasu","year":"1986","journal-title":"Gastroenterology"},{"key":"key20180107231613_b22-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(76)92281-9","article-title":"Percutaneous transhepatic obliteration of gastro-oesophageal varices","volume":"2","author":"Scott","year":"1976","journal-title":"Lancet"},{"key":"key20180107231613_b23-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/hep.1840180214","article-title":"Partial splenic embolization for the treatment of hypersplenism in cirrhosis","volume":"18","author":"Sangro","year":"1993","journal-title":"Hepatology"},{"key":"key20180107231613_b24-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/00000658-198211000-00003","article-title":"Evaluation of splenic embolization in patients with portal hypertension and hypersplenism","volume":"196","author":"Alwmark","year":"1982","journal-title":"Ann Surg"},{"key":"key20180107231613_b25-ijmm-33-05-1131","first-page":"213","article-title":"Decrease of insulin resistance after splenectomy in a diabetic patient with liver cirrhosis and portal hypertension. Physiopathologic evaluation","volume":"40","author":"Moro","year":"1994","journal-title":"Minerva Gastroenterol Dietol"},{"key":"key20180107231613_b26-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00423-002-0342-6","article-title":"Partial splenic embolization: long-term outcome","volume":"387","author":"P\u00e5lsson","year":"2003","journal-title":"Langenbecks Arch Surg"},{"key":"key20180107231613_b27-ijmm-33-05-1131","first-page":"1445","article-title":"Long-term hematological and biochemical effects of partial splenic embolization in hepatic cirrhosis","volume":"49","author":"Tajiri","year":"2002","journal-title":"Hepatogastroenterology"},{"key":"key20180107231613_b28-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/j.lfs.2007.03.009","article-title":"Splenic hemodynamics and decreased endothelial nitric oxide synthase in the spleen of rats with liver cirrhosis","volume":"80","author":"Yamaguchi","year":"2007","journal-title":"Life Sci"},{"key":"key20180107231613_b29-ijmm-33-05-1131","first-page":"1745","article-title":"A novel, simple method of functional spleen volume calculation by liver-spleen scan","volume":"40","author":"Hoefs","year":"1999","journal-title":"J Nucl Med"},{"issue":"Suppl 1","key":"key20180107231613_b30-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0037-1963(00)90113-6","article-title":"The spleen: anatomy and anatomical function","volume":"37","author":"Chadburn","year":"2000","journal-title":"Semin Hematol"},{"key":"key20180107231613_b31-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.4049\/jimmunol.181.8.5264","article-title":"Splenic phagocytes promote responses to nucleosomes in (NZB \u00d7 NZW) F1 mice","volume":"181","author":"Okamoto","year":"2008","journal-title":"J Immunol"},{"key":"key20180107231613_b32-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3748\/wjg.v12.i8.1205","article-title":"Autoimmune thrombocytopenia in response to splenectomy in cirrhotic patients with accompanying hepatitis C","volume":"12","author":"Sekiguchi","year":"2006","journal-title":"World J Gastroenterol"},{"key":"key20180107231613_b33-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.3748\/wjg.14.2377","article-title":"Changes in count and function of splenic lymphocytes from patients with portal hypertension","volume":"14","author":"Li","year":"2008","journal-title":"World J Gastroenterol"},{"key":"key20180107231613_b34-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"key20180107231613_b35-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.4049\/jimmunol.165.11.6107","article-title":"Microbial lipopeptides induce the production of IL-17 in Th cells","volume":"165","author":"Infante-Duarte","year":"2000","journal-title":"J Immunol"},{"key":"key20180107231613_b36-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat Immunol"},{"key":"key20180107231613_b37-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2893.2011.01561.x","article-title":"Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis","volume":"19","author":"Sun","year":"2012","journal-title":"J Viral Hepat"},{"key":"key20180107231613_b38-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/hep.22680","article-title":"The interleukin-17 pathway is involved in human alcoholic liver disease","volume":"49","author":"Lemmers","year":"2009","journal-title":"Hepatology"},{"key":"key20180107231613_b39-ijmm-33-05-1131","first-page":"385","article-title":"IL-17 expression is correlated with hepatitis B-related liver diseases and fibrosis","volume":"27","author":"Wang","year":"2011","journal-title":"Int J Mol Med"},{"key":"key20180107231613_b40-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s10875-010-9416-3","article-title":"Involvement of Th17 and Th1 effector responses in patients with Hepatitis B","volume":"30","author":"Ye","year":"2010","journal-title":"J Clin Immunol"},{"key":"key20180107231613_b41-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.dld.2011.11.005","article-title":"Hepatitis B virus particles preferably induce Kupffer cells to produce TGF-\u03b21 over pro-inflammatory cytokines","volume":"44","author":"Li","year":"2012","journal-title":"Dig Liver Dis"},{"key":"key20180107231613_b42-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"key20180107231613_b43-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature04754","article-title":"Transforming growth factor-beta induces development of the T(H)17 lineage","volume":"441","author":"Mangan","year":"2006","journal-title":"Nature"},{"key":"key20180107231613_b44-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells","volume":"24","author":"Veldhoen","year":"2006","journal-title":"Immunity"},{"key":"key20180107231613_b45-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1002\/eji.200737810","article-title":"IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells","volume":"37","author":"Niedbala","year":"2007","journal-title":"Eur J Immunol"},{"key":"key20180107231613_b46-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ni.1952","article-title":"IL-35-mediated induction of a potent regulatory T cell population","volume":"11","author":"Collison","year":"2010","journal-title":"Nat Immunol"},{"key":"key20180107231613_b47-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/eji.200838145","article-title":"Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and RORgamma t","volume":"38","author":"Yang","year":"2008","journal-title":"Eur J Immunol"},{"key":"key20180107231613_b48-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"key20180107231613_b49-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"key20180107231613_b50-ijmm-33-05-1131","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni909","article-title":"An essential role for Scurfin in CD4+CD25+ T regulatory cells","volume":"4","author":"Khattri","year":"2003","journal-title":"Nat Immunol"}],"container-title":["International Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijmm.2014.1662\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T14:03:07Z","timestamp":1597500187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijmm.2014.1662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,19]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,2,19]]},"published-print":{"date-parts":[[2014,5]]}},"alternative-id":["10.3892\/ijmm.2014.1662"],"URL":"https:\/\/doi.org\/10.3892\/ijmm.2014.1662","relation":{},"ISSN":["1107-3756","1791-244X"],"issn-type":[{"value":"1107-3756","type":"print"},{"value":"1791-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,19]]}}}